Lutz Schneider1, Pietro Contin2, Stefan Fritz2, Oliver Strobel2, Markus W Büchler2, Thilo Hackert2. 1. Department for General, Visceral and Transplantation Surgery, University of Heidelberg, Germany. Electronic address: Markus.Buechler@med.uni-heidelberg.de. 2. Department for General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.
Abstract
INTRODUCTION: Benign neoplastic, inflammatory or functional pathologies of the ampulla of Vater are mainly treated by primary endoscopic interventions. Consequently, transduodenal surgical ampullectomy (TSA) has been abandoned in many centres, although it represents an important tool not only after unsuccessful endoscopic treatment. The aim of the study was to analyse TSA for benign lesions of the ampulla of Vater. PATIENTS AND METHODS: All patients who underwent TSA between 2001 and 2014 were included. Patients were analysed in terms of indications, postoperative morbidity and mortality as well as long-term success. RESULTS: Eighty-three patients underwent TSA. Indications included adenomas in 44 and inflammatory stenosis in 39 patients. 96% of the patients had undergone endoscopic therapeutic approaches prior to TSA (median no. of interventions n = 3). Postoperative morbidity occurred in 20 patients (24%). There was one procedure-associated death (mortality 1.2%). The mean follow-up was 54 months. Long-term overall success rate for TSA was 83.6%. After TSA for ampullary adenoma, the recurrence rate was 4.5%. CONCLUSION: TSA is an underestimated surgical procedure, which can be performed safely with high long-term efficacy. It can be implemented in clinical algorithms for patients with benign pathologies of the ampulla of Vater, particularly after unsuccessful endoscopic treatment.
INTRODUCTION: Benign neoplastic, inflammatory or functional pathologies of the ampulla of Vater are mainly treated by primary endoscopic interventions. Consequently, transduodenal surgical ampullectomy (TSA) has been abandoned in many centres, although it represents an important tool not only after unsuccessful endoscopic treatment. The aim of the study was to analyse TSA for benign lesions of the ampulla of Vater. PATIENTS AND METHODS: All patients who underwent TSA between 2001 and 2014 were included. Patients were analysed in terms of indications, postoperative morbidity and mortality as well as long-term success. RESULTS: Eighty-three patients underwent TSA. Indications included adenomas in 44 and inflammatory stenosis in 39 patients. 96% of the patients had undergone endoscopic therapeutic approaches prior to TSA (median no. of interventions n = 3). Postoperative morbidity occurred in 20 patients (24%). There was one procedure-associated death (mortality 1.2%). The mean follow-up was 54 months. Long-term overall success rate for TSA was 83.6%. After TSA for ampullary adenoma, the recurrence rate was 4.5%. CONCLUSION:TSA is an underestimated surgical procedure, which can be performed safely with high long-term efficacy. It can be implemented in clinical algorithms for patients with benign pathologies of the ampulla of Vater, particularly after unsuccessful endoscopic treatment.
Authors: Eugene P Ceppa; Rebecca A Burbridge; Kristy L Rialon; Philip A Omotosho; Dawn Emick; Paul S Jowell; Malcom Stanley Branch; Theodore N Pappas Journal: Ann Surg Date: 2013-02 Impact factor: 12.969
Authors: Lutz Schneider; Elias Müller; Ulf Hinz; Lars Grenacher; Markus W Büchler; Jens Werner Journal: World J Surg Date: 2011-06 Impact factor: 3.352
Authors: Shayan Irani; Andrew Arai; Kamran Ayub; Thomas Biehl; John J Brandabur; Russell Dorer; Michael Gluck; Geoffrey Jiranek; David Patterson; Drew Schembre; L William Traverso; Richard A Kozarek Journal: Gastrointest Endosc Date: 2009-07-15 Impact factor: 9.427
Authors: Ian D Norton; Christopher J Gostout; Todd H Baron; Alex Geller; Bret T Petersen; Maurits J Wiersema Journal: Gastrointest Endosc Date: 2002-08 Impact factor: 9.427
Authors: Edwin O Onkendi; Nimesh D Naik; Jordan K Rosedahl; Scott W Harmsen; Christopher J Gostout; Todd H Baron; Michael G Sarr; Florencia G Que Journal: J Gastrointest Surg Date: 2014-06-11 Impact factor: 3.452
Authors: Verushka M Mansukhani; Gunjan S Desai; Sasi Mouli; Keval Shirodkar; Rajiv C Shah; Jagannath Palepu Journal: Indian J Gastroenterol Date: 2017-01-05
Authors: Enrique Pérez-Cuadrado-Robles; Hubert Piessevaux; Tom G Moreels; Ralph Yeung; Tarik Aouattah; Mina Komuta; Hélène Dano; Anne Jouret-Mourin; Pierre H Deprez Journal: United European Gastroenterol J Date: 2019-01-12 Impact factor: 4.623
Authors: Kheman Rajkomar; Michelle Kweon; Imran Khan; Paul Frankish; Michael Rodgers; Jonathan B Koea Journal: World J Gastrointest Endosc Date: 2017-04-16
Authors: Marcus Hollenbach; Einas Abou Ali; Francesco Auriemma; Aiste Gulla; Christian Heise; Sara Regnér; Sébastien Gaujoux Journal: Front Med (Lausanne) Date: 2020-05-06